Expand SGMT Menu
SGMT MENU

SGMT Stock Posts


Unusual Option Volume

SGMT Sagimet Biosciences - Series A8.26+2.40 (+41.0%)

Sagimet Biosciences - Series A trades 2,712 contracts. The company has the following event: KOL event and webcast to discuss planned development of denifanstat for acne on Apr 30, 2026. News: Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A6.22+0.26 (+4.4%)

Sagimet Biosciences - Series A trades 2,556 contracts.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A9.43+0.82 (+9.5%)

Sagimet Biosciences - Series A trades 2,648 contracts. The company has the following event: A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne on Jun 16, 2025.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A8.07+1.88 (+30.4%)

Sagimet Biosciences - Series A trades 3,118 contracts. The company has the following event: A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne on Jun 16, 2025.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A5.49+0.71 (+14.9%)

Sagimet Biosciences - Series A trades 2,517 contracts.
View Details...
Unusual Option Volume

SGMT Sagimet Biosciences - Series A5.12+1.04 (+25.5%)

Sagimet Biosciences - Series A trades 2,426 contracts. News: Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes